Skip to content
Search

Latest Stories

Sri Lanka raises rates as rupee falls to record low

Sri Lanka raises rates as rupee falls to record low

SRI Lanka's central bank raised interest rates for the first time in nearly three years on Thursday (19) as the rupee hit a record low amid a crippling foreign exchange shortage.

With the country of 21 million already facing shortages of imported cooking gas and sugar because of the shortage of dollars, the Central Bank of Sri Lanka increased its deposit and lending rates by 50 basis points to 5.0 per cent and 6.0 per cent respectively.


The bank said the move was to counter "imbalances" as the rupee fell against the dollar "and to preempt the buildup of any excessive inflationary pressures".

The rupee fell to 216.55 against the dollar - its lowest ever level - despite the central bank urging currency traders not to allow the local currency to fall below 202.

The government had reduced rates after the coronavirus pandemic hit last year in hope of bolstering the economy.

But Sri Lanka still recorded its worst recession in decades, with the economy shrinking 3.6 per cent as tourist arrivals collapsed and with it foreign currency receipts.

Sri Lanka's foreign reserves fell to $2.8 billion (£2b) at the end of July, from $7.5b (£5.4b) in November 2019 when the government took office.

The rupee has lost nearly 20 per cent of its value against the US dollar in that time, according to data from private banks.

Faced with currency shortages, the government banned a wide range of imports, including vehicles as well as industrial raw materials and machinery since March last year.

With supermarkets rationing staples such as sugar and milk powder, importers say they cannot get dollars at official exchange rates and have to pay black market prices.

Energy minister Udaya Gammanpila appealed to motorists this week to use fuel sparingly so that the country can use its foreign exchange to buy essential medicines and vaccines.

Another top official warned that fuel rationing may be introduced by the end of the year unless consumption was reduced.

Last month, the Moody's ratings agency placed Sri Lanka under watch for a downgrade on persistent fears that the island could default on its foreign debt.

Sri Lanka's annual foreign debt servicing is estimated at $4b to $5b (£2.9b to £3.6b) over the next four to five years, Moody's said.

The country has arranged a $250 million (£182.6m) loan from Bangladesh, and similar cash injections from India, China and South Korea.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less